E286 - Building Cell Therapy Companies With Kenai Therapeutics' Nick Manusos

We love to hear from our listeners. Send us a message.

On this week's episode of the Business of Biotech, Nick Manusos, CEO at Kenai Therapeutics, talks about his experiences building cell therapy spinouts from FujiFilm Cellular Dynamics, learning from big pharma decision-making processes, and dosing the first patient with Kenai's allogeneic neuron replacement cell therapy for Parkinson's disease. Nick also talks about funding an early-stage cell therapy company and forging key manufacturing and therapy administration partnerships. 

Access this and hundreds of episodes of the Business of Biotech videocast under the Business o...